Qbiogene has recognized that the enormous growth in biotechnology research is forcing companies to outsource. In addition insufficient manufacturing capacity is also a problem. Qbiogene can take advantage of these trends by offering research companies the possibility of outsourcing complete processes from initial research to laboratory testing to manufacturing.

In this way Qbiogene can leverage its expertise to generate repeat business and create a well-diversified revenue base. This gives the company a unique selling position in what is otherwise a highly fragmented industry. This is the basis of the company’s strategy.

Qbiogene’s unique business model is based on in-house developed, in-licensed or acquired research and development. Building on these mastered techniques, Qbiogene further offers standard research tools and services for basic research, customized research products and services for pre-clinical research leading up to clinic grade manufacturing capacities. This covers the complete continuum of the molecular and cellular biology research spectrum from gene cloning, selection and expression to biopharmaceutical production.

Qbiogene is gradually changing its profile from basic research products to include more value added products in customized research and manufacturing.